Clinical Trials in Massachusetts

Showing 2181-2200 of 8,511 trials

Speech, Linguistic and Acoustic Markers in Parkinson's Disease

NCT04273672

The Investigators aim to identify speech and language markers that provide information on cognitive function and predict cognitive decline in Parkinson's disease. The Investigators will administer speech tasks and cognitive assessments to participants with Parkinson's disease and healthy controls. The Investigators will also explore the associations between genetic factors and speech and cognitive status in Parkinson's disease.

Parkinson DiseaseCognitive Impairment, MildSpeech

University of Massachusetts, Worcester58 participantsStarted Jan 2020

Worcester, Massachusetts, United States

RECRUITINGNA26 miles

TRIcvalve biCAVal Valve System for Severe Tricuspid Regurgitation (TRICAV-I)

NCT06137807

The TricValve® Transcatheter Bicaval Valve System is a bicaval transcatheter tricuspid valve replacement system, which includes the TricValve® Transcatheter Bicaval Valve for superior vena cava (SVC) and the TricValve® Transcatheter Bicaval Valve for inferior vena cava (IVC). The TricValve® Transcatheter Bicaval Valves are pre-mounted into the TricValve® Delivery System which is used for percutaneous access and delivery of the TricValve® Transcatheter Bicaval Valve in the vena cava. The system is a single use, sterile device compatible with all the valve sizes. The prostheses are implanted percutaneously into the inferior and superior vena cava without disturbing the native tricuspid valve. The device is made of bovine pericardium leaflets sutured on a nitinol self-expanding stent system.

Tricuspid RegurgitationTricuspid Valve Disease

P+F Products + Features USA Inc.50 participantsStarted Jul 2024

Phoenix, Arizona, United States • Tucson, Arizona, United States • San Diego, California, United States +33 more locations

Speech, Linguistic and Acoustic Markers in Parkinson's Disease

TRIcvalve biCAVal Valve System for Severe Tricuspid Regurgitation (TRICAV-I)

Find Trials by Condition in Massachusetts

Ascending Doses of Crofelemer Powder for Oral Solution in Pediatric Microvillus Inclusion Disease (MVID)

Early Intervention

Nemvaleukin Alfa Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Cutaneous or Mucosal Melanoma - ARTISTRY-6

JAGUAR Trial: ObJective Analysis to GaUge EVAR Outcomes Through Randomization

Promoting Shared Decision Making for Severe Aortic Stenosis

TAC T-cells for the Treatment of HER2-positive Solid Tumors

Study of Orally Administered AG-120 in Subjects With Advanced Hematologic Malignancies With an IDH1 Mutation

Prepping for The Talk: Helping Trusted Adults and Youth Talk About Sexual Health

A 52-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough

Pomalidomide in Combination With Low-dose Dexamethasone or Pomalidomide in Combination With Low-dose Dexamethasone and Daratumumab in Subjects With Relapsed or Refractory Multiple Myeloma Following Lenalidomide-based Therapy in the First or Second Line Setting

Study of the Efficacy and Safety PF-06741086 in Adult and Teenage Participants With Severe Hemophilia A or Moderately Severe to Severe Hemophilia B

ZZ06 in Adult Patients With Advanced Solid Tumor Malignancies

Study of IBI3020 Treatment in Participants With Late-Stage Solid Tumors

D-PLEX 312 - Safety and Efficacy of D-PLEX in the Prevention of Post Abdominal Surgery Incisional Infection (SHIELD II)

Long-Term Follow-Up Gene Therapy Study for Achromatopsia CNGB3 and CNGA3

A Study to Assess Safety and Target Engagement of E2814 in Participants With Mild to Moderate Cognitive Impairment Due to Dominantly Inherited Alzheimer's Disease

ProVIDE II Bridging Study

A Study Evaluating the Safety and Efficacy of MINIject S+ in Subjects With Open Angle Glaucoma